Arcutis Biotherapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 105.4M | 129.5M | 99.2M | 81.5M | 65.8M | 71.4M | 44.8M | 30.9M |
| Cost of Goods Sold | 9.8M | 11.7M | 8.7M | 7.5M | 8.8M | 6.9M | 5.5M | 3.5M |
| Gross Profit | 95.6M | 117.8M | 90.5M | 74.0M | 57.0M | 64.5M | 39.3M | 27.4M |
| R&D Expenses | 30.6M | 20.5M | 19.6M | 19.5M | 17.5M | 14.5M | 19.5M | 19.3M |
| Operating Expenses | 104.7M | 99.4M | 82.0M | 88.6M | 81.5M | 72.1M | 78.3M | 77.5M |
| Operating Income | -9.1M | 18.4M | 8.5M | -14.6M | -24.5M | -7.6M | -39.1M | -50.1M |
| Other Income / Gains | -2.1M | -522K | -1.0M | -933K | -252K | -2.8M | -2.5M | -2.3M |
| Net Income | -11.3M | 17.4M | 7.4M | -15.9M | -25.1M | -10.8M | -41.5M | -52.3M |
| EPS (Diluted) | -0.087 | 0.14 | 0.058 | -0.13 | -0.20 | -0.089 | -0.33 | -0.42 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.907 | 0.91 | 0.912 | 0.908 | 0.866 | 0.903 | 0.877 | 0.888 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 74.1M | 79.0M | 62.4M | 69.2M | 64.0M | 57.6M | 58.8M | 58.2M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 114.5M | 111.1M | 90.7M | 96.1M | 90.4M | 79.0M | 83.8M | 80.9M |
| Interest Income | 2.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.4M | 3.0M | 3.1M | 3.0M | 3.0M | 5.6M | 6.7M | 7.5M |
| Depreciation And Amortization | 562K | 1.3M | 562K | 563K | 3.1M | 458K | 1.4M | 351K |
| Ebitda | -8.5M | 22.1M | 11.1M | -12.0M | -18.7M | -4.5M | -33.5M | -44.5M |
| Ebitdaratio | -0.081 | 0.171 | 0.112 | -0.147 | -0.283 | -0.062 | -0.747 | -1.442 |
| Operating Income Ratio | -0.086 | 0.142 | 0.086 | -0.179 | -0.373 | -0.107 | -0.873 | -1.623 |
| Income Before Tax | -11.2M | 17.9M | 7.5M | -15.5M | -24.8M | -10.5M | -41.5M | -52.3M |
| Income Before Tax Ratio | -0.106 | 0.138 | 0.075 | -0.191 | -0.376 | -0.147 | -0.928 | -1.696 |
| Income Tax Expense | 93K | 470K | 80K | 342K | 279K | 323K | 0 | 0 |
| Net Income Ratio | -0.107 | 0.134 | 0.075 | -0.195 | -0.381 | -0.151 | -0.928 | -1.696 |
| Epsdiluted | -0.087 | 0.13 | 0.056 | -0.13 | -0.20 | -0.089 | -0.33 | -0.42 |
| Weighted Average Shs Out | 129.4M | 128.3M | 127.6M | 127.0M | 126.0M | 121.0M | 124.3M | 123.5M |
| Weighted Average Shs Out Dil | 129.4M | 135.6M | 132.9M | 127.0M | 126.0M | 121.0M | 124.3M | 123.5M |